176 related articles for article (PubMed ID: 12776264)
1. An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism.
Strippoli GF; Manno C; Schena FP
Am J Kidney Dis; 2003 Jun; 41(6):1129-39. PubMed ID: 12776264
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic approach of patients with IgA nephropathy.
Goumenos DS; Brown CB
Ren Fail; 2004 Mar; 26(2):171-7. PubMed ID: 15287202
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials.
Samuels JA; Strippoli GF; Craig JC; Schena FP; Molony DA
Nephrology (Carlton); 2004 Aug; 9(4):177-85. PubMed ID: 15363047
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials.
Zhang Z; Yang Y; Jiang SM; Li WG
BMC Nephrol; 2019 Aug; 20(1):333. PubMed ID: 31455248
[TBL] [Abstract][Full Text] [Related]
5. Treatment of immunoglobulin A nephropathy.
Schiele J; Nowack R; Julian BA; van der Woude FJ
Ann Med Interne (Paris); 1999 Feb; 150(2):127-36. PubMed ID: 10392261
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive agents for treating IgA nephropathy.
Samuels JA; Strippoli GF; Craig JC; Schena FP; Molony DA
Cochrane Database Syst Rev; 2003; (4):CD003965. PubMed ID: 14584001
[TBL] [Abstract][Full Text] [Related]
7. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
Min L; Wang Q; Cao L; Zhou W; Yuan J; Zhang M; Che X; Mou S; Fang W; Gu L; Zhu M; Wang L; Yu Z; Qian J; Ni Z
Oncotarget; 2017 Jul; 8(29):48375-48384. PubMed ID: 28415636
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid therapy in IgA nephropathy.
Lv J; Xu D; Perkovic V; Ma X; Johnson DW; Woodward M; Levin A; Zhang H; Wang H;
J Am Soc Nephrol; 2012 Jun; 23(6):1108-16. PubMed ID: 22539830
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria.
Zhong Z; Tang Y; Tan J; Tan L; Pei G; Qin W
Int Urol Nephrol; 2021 Jan; 53(1):121-127. PubMed ID: 32944888
[TBL] [Abstract][Full Text] [Related]
10. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
Branten AJ; Klasen IS; Wetzels JF
Clin Nephrol; 2002 Oct; 58(4):267-74. PubMed ID: 12400841
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol in the treatment of IgA nephropathy with non-nephrotic range proteinuria: a meta-analysis of randomized controlled trials
.
Deng J; Zheng X; Xie H; Chen L
Clin Nephrol; 2017 Jan; 87 (2017)(1):21-27. PubMed ID: 27900938
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
14. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of randomised controlled trials in patients with primary IgA nephropathy (Berger's disease).
Schena FP; Montenegro M; Scivittaro V
Nephrol Dial Transplant; 1990; 5 Suppl 1():47-52. PubMed ID: 2151741
[TBL] [Abstract][Full Text] [Related]
16. Potential benefits and related treatment effects of calcineurin inhibitors combined with steroid for IgA nephropathy: a systematic review and meta-analysis.
Li Z; Yang Z; Ji M
Int Urol Nephrol; 2023 Sep; 55(9):2227-2236. PubMed ID: 36856924
[TBL] [Abstract][Full Text] [Related]
17. Prognostic indicators and treatment of childhood IgA nephropathy.
Hogg RJ
Contrib Nephrol; 1995; 111():194-9; discussion 199-200. PubMed ID: 7758342
[No Abstract] [Full Text] [Related]
18. Omega-3 fatty acids ameliorate proteinuria but not renal function in IgA nephropathy: a meta-analysis of randomized controlled trials.
Chou HH; Chiou YY; Hung PH; Chiang PC; Wang ST
Nephron Clin Pract; 2012; 121(1-2):c30-5. PubMed ID: 23095320
[TBL] [Abstract][Full Text] [Related]
19. Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases.
Kobayashi Y; Fujii K; Hiki Y; Tateno S; Kurokawa A; Kamiyama M
Nephron; 1988; 48(1):12-7. PubMed ID: 3340251
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.
Sarcina C; Tinelli C; Ferrario F; Visciano B; Pani A; De Silvestri A; De Simone I; Del Vecchio L; Terraneo V; Furiani S; Santagostino G; Corghi E; Pozzi C
PLoS One; 2016; 11(7):e0158584. PubMed ID: 27416024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
